{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/clino-and-clino-md-compliance-in-submissions-and-conduct”
},
“@id”: “https://www.clinicalstudies.in/clino-and-clino-md-compliance-in-submissions-and-conduct”,
“headline”: “SOP for ClinO and ClinO-MD Compliance in Submissions and Conduct”,
“name”: “SOP for ClinO and ClinO-MD Compliance in Submissions and Conduct”,
“description”: “Detailed SOP describing sponsor, investigator, and regulatory responsibilities for ensuring compliance with ClinO and ClinO-MD regulations for clinical trial submissions and conduct in Switzerland under Swissmedic.”,
“keywords”: “Swissmedic ClinO SOP, SOP for ClinO compliance, SOP for ClinO-MD submissions, Swiss clinical trial submission SOP, SOP for regulatory compliance Switzerland, SOP for sponsor responsibilities Swissmedic, SOP for investigator site ClinO compliance, SOP for essential documents ClinO, SOP for safety reporting ClinO Swissmedic, SOP for trial approvals Switzerland, SOP for medical device ClinO-MD SOP, SOP for Swiss ethics submissions, SOP for inspection readiness Switzerland, SOP for bilingual documentation Switzerland, SOP for Swiss retention requirements, SOP for GCP compliance Swissmedic, SOP for protocol amendments Swissmedic, SOP for SUSAR reporting Switzerland, SOP for trial governance Switzerland, SOP for regulatory submissions Swissmedic, SOP for document archiving Switzerland, SOP for trial conduct ClinO, SOP for investigator brochure submissions Switzerland, SOP for trial governance ClinO Switzerland, SOP for compliance with Swiss regulations”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

ClinO and ClinO-MD Compliance in Submissions and Conduct SOP

Purpose

The purpose of this SOP is to define processes for ensuring compliance with the Swiss Ordinance on Clinical Trials in Human Research (ClinO) and the Ordinance on Clinical Trials with Medical Devices (ClinO-MD). It outlines the submission, approval, conduct, monitoring, and reporting requirements under Swissmedic, ensuring ethical and regulatory adherence.

Scope

This SOP applies to all clinical trials involving medicinal products and medical devices conducted in Switzerland under ClinO and ClinO-MD regulations. It covers sponsor obligations, investigator responsibilities, ethics committee submissions, safety reporting, amendments, and archiving of trial documents.

Responsibilities

• Sponsor: Ensures compliance with ClinO and ClinO-MD requirements, prepares submission dossiers, and maintains oversight.
• Regulatory Affairs (RA): Submits dossiers to Swissmedic and BASEC (ethics committee) and tracks approvals.
• Principal Investigator (PI): Conducts trials per ClinO/ClinO-MD, maintains documentation, and ensures subject safety.
• Clinical Project Manager (CPM): Coordinates timelines and ensures trial conduct is aligned with approvals.
• Quality Assurance (QA): Audits trial documents and processes to ensure readiness for inspections.

Accountability

The Sponsor’s Head of Regulatory Affairs is accountable for compliance with ClinO/ClinO-MD obligations. The PI is accountable for site-level adherence and subject protection.

Procedure

1. Preparation of Submission Dossier

1. Compile CTA dossier including protocol, Investigator’s Brochure, ICF, IMPD (for drugs), or device dossier (for medical devices).
2. Ensure translations into German, French, or Italian as required.
3. Maintain Submission Checklist (Annexure-1).

2. Submissions to Swissmedic and BASEC

1. Submit dossiers electronically through Swissmedic and BASEC portals.
2. Record submission acknowledgments in Submission Log.

3. Trial Conduct and Monitoring

1. Conduct trial in compliance with ClinO/ClinO-MD, GCP, and local ethics requirements.
2. Maintain Trial Master File (TMF) with all essential documents.

4. Safety Reporting

1. Submit SUSARs to Swissmedic and BASEC within required timelines.
2. Report annual safety updates (DSURs) to authorities.

5. Protocol Amendments

1. Submit substantial amendments to Swissmedic and BASEC prior to implementation.
2. Record approvals in Amendment Log (Annexure-2).

6. Archiving

1. Archive TMF and ISF records for at least 10 years or as per ClinO retention requirements.

Abbreviations

• ClinO: Ordinance on Clinical Trials in Human Research
• ClinO-MD: Ordinance on Clinical Trials with Medical Devices
• Swissmedic: Swiss Agency for Therapeutic Products
• BASEC: Business Administration System for Ethics Committees
• CTA: Clinical Trial Application
• ICF: Informed Consent Form
• IMPD: Investigational Medicinal Product Dossier
• PI: Principal Investigator
• RA: Regulatory Affairs
• QA: Quality Assurance
• CPM: Clinical Project Manager
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. Submission Checklist (Annexure-1)
2. Amendment Log (Annexure-2)
3. Safety Reporting Log (Annexure-3)

References

• Swissmedic — Clinical Trials
• BASEC — Ethics Committees Switzerland
• ICH E6(R2) Good Clinical Practice

Version: 1.0

Approval

Annexures

Annexure-1: Submission Checklist

Annexure-2: Amendment Log

Annexure-3: Safety Reporting Log

Revision History

For more SOPs visit: Pharma SOP.

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/swiss-ethics-and-basec-submissions-and-communications”
},
“@id”: “https://www.clinicalstudies.in/swiss-ethics-and-basec-submissions-and-communications”,
“headline”: “SOP for Swiss Ethics and BASEC Submissions and Communications”,
“name”: “SOP for Swiss Ethics and BASEC Submissions and Communications”,
“description”: “Comprehensive SOP for managing submissions and communications with Swiss Ethics Committees (via BASEC) in compliance with Swissmedic regulations and ICH GCP.”,
“keywords”: “Swiss ethics submission SOP, BASEC submission SOP, SOP for Swiss EC communications, SOP for ethics approval Switzerland, SOP for site-level ethics submissions, SOP for sponsor responsibilities Swiss ethics, SOP for trial governance Switzerland, SOP for clinical trial application Swiss ethics, SOP for EC correspondence management, SOP for investigator EC compliance, SOP for ethics resubmissions Switzerland, SOP for dual submission Swissmedic BASEC, SOP for cultural and linguistic compliance Switzerland, SOP for document archiving Switzerland, SOP for protocol amendments EC Switzerland, SOP for safety reporting EC Switzerland, SOP for ethics committee meeting minutes Switzerland, SOP for sponsor-EC interactions Switzerland, SOP for trial lifecycle ethics Switzerland, SOP for ethics approval tracker, SOP for inspection readiness ethics submissions Switzerland, SOP for communication logs Switzerland, SOP for ethics documentation Switzerland, SOP for sponsor QA Swiss ethics, SOP for site ethics compliance Switzerland”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Swiss Ethics and BASEC Submissions and Communications SOP

Purpose

This SOP outlines procedures for preparing, submitting, and managing communications with Swiss Ethics Committees via the Business Administration System for Ethics Committees (BASEC). It ensures compliance with Swissmedic regulations, ICH GCP, and ethical governance requirements in Switzerland.

Scope

This SOP applies to all sponsor-led and investigator-initiated clinical trials conducted in Switzerland requiring submission to Swiss Ethics Committees through BASEC. It covers initial submissions, responses to ethics queries, substantial amendments, safety reporting, communications, and documentation archiving.

Responsibilities

• Sponsor: Ensures complete and timely ethics submissions through BASEC and maintains oversight of communications.
• Regulatory Affairs (RA): Prepares submission dossiers, manages BASEC portal entries, and tracks approval status.
• Principal Investigator (PI): Provides site-specific documentation and ensures compliance with approved protocols.
• Clinical Project Manager (CPM): Tracks submission timelines and ensures communication logs are maintained.
• Quality Assurance (QA): Audits ethics submissions and ensures inspection readiness.

Accountability

The Sponsor’s Head of Regulatory Affairs is accountable for ethics submissions and communications. The PI is accountable for ensuring site compliance with approved ethics requirements.

Procedure

1. Preparation of Ethics Submission

1. Compile submission package including protocol, ICF, IB, recruitment materials, insurance certificate, and investigator CVs.
2. Translate documents into German, French, or Italian as required by the region.
3. Maintain Submission Checklist (Annexure-1).

2. Submission through BASEC

1. Submit the complete application electronically through the BASEC portal.
2. Record submission reference number and acknowledgment in Submission Log.

3. Ethics Committee Communication

1. Respond promptly to EC queries through the BASEC portal within defined timelines.
2. Maintain Communication Log documenting correspondence with ethics committees.

4. Substantial Amendments

1. Prepare amended documents with tracked changes.
2. Submit amendments through BASEC prior to implementation.
3. Record approvals in Amendment Log (Annexure-2).

5. Safety Reporting

1. Submit SUSARs and DSURs to ECs via BASEC as per timelines.
2. Ensure acknowledgment receipts are retained in TMF.

6. Documentation and Archiving

1. Maintain ethics approval letters, submission logs, and correspondence in TMF.
2. Archive ethics records for at least 10 years or per Swiss retention requirements.

Abbreviations

• BASEC: Business Administration System for Ethics Committees
• EC: Ethics Committee
• Swissmedic: Swiss Agency for Therapeutic Products
• ICF: Informed Consent Form
• IB: Investigator’s Brochure
• CTA: Clinical Trial Application
• PI: Principal Investigator
• RA: Regulatory Affairs
• QA: Quality Assurance
• CPM: Clinical Project Manager
• TMF: Trial Master File

Documents

1. Submission Checklist (Annexure-1)
2. Amendment Log (Annexure-2)
3. Communication Log (Annexure-3)

References

• Swiss Ethics Committees (BASEC)
• Swissmedic — Clinical Trials
• ICH E6(R2) Good Clinical Practice

Version: 1.0

Approval

Annexures

Annexure-1: Submission Checklist

Annexure-2: Amendment Log

Annexure-3: Communication Log

Revision History

For more SOPs visit: Pharma SOP.

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/multilingual-documentation-and-country-retention-rules”
},
“@id”: “https://www.clinicalstudies.in/multilingual-documentation-and-country-retention-rules”,
“headline”: “SOP for Multilingual Documentation and Country Retention Rules”,
“name”: “SOP for Multilingual Documentation and Country Retention Rules”,
“description”: “Comprehensive SOP describing sponsor and investigator responsibilities for multilingual documentation preparation and adherence to Swiss country-specific retention requirements for clinical trials.”,
“keywords”: “multilingual documentation SOP Switzerland, Swiss trial document retention SOP, SOP for clinical trial translation Switzerland, SOP for document localization Switzerland, SOP for archiving Swiss trial documents, SOP for multilingual ICFs Switzerland, SOP for sponsor responsibilities Swiss documentation, SOP for BASEC submission multilingual documents, SOP for retention ClinO Switzerland, SOP for inspection readiness Switzerland, SOP for record keeping SOP Switzerland, SOP for document governance Switzerland, SOP for regulatory submissions multilingual Switzerland, SOP for language compliance Swiss clinical trials, SOP for document archival retention Switzerland, SOP for clinical trial document translation QA, SOP for bilingual Swiss trial governance, SOP for translation vendor management Switzerland, SOP for document authenticity Switzerland, SOP for sponsor-site responsibilities Switzerland, SOP for TMF retention Switzerland, SOP for ISF retention Switzerland, SOP for GCP compliance Switzerland, SOP for ethics submission multilingual Switzerland, SOP for patient document translation Switzerland”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Multilingual Documentation and Country Retention Rules SOP

Purpose

This SOP defines the process for preparing multilingual documentation and complying with Switzerland’s specific retention rules for clinical trial documentation. It ensures that subject-facing documents and regulatory submissions are linguistically and legally compliant under Swissmedic and BASEC requirements.

Scope

This SOP applies to all clinical trials conducted in Switzerland, covering translation, back-translation, certification, and retention of essential trial documents including informed consent forms, patient information sheets, investigator brochures, protocols, and safety reports. It applies to sponsors, investigators, CROs, regulatory affairs, and translation vendors.

Responsibilities

• Sponsor: Ensures multilingual documents are prepared, validated, and archived per ClinO requirements.
• Regulatory Affairs (RA): Submits translated documents to BASEC and Swissmedic as required.
• Principal Investigator (PI): Provides translated subject-facing documents at site and ensures participant comprehension.
• Translation Vendor: Provides certified translations and back-translations of all essential documents.
• Quality Assurance (QA): Audits translated materials and ensures retention timelines are respected.

Accountability

The Sponsor’s Head of Clinical Operations is accountable for multilingual documentation compliance and adherence to Swiss retention rules. The PI is accountable for ensuring subjects receive translated materials in appropriate languages (German, French, Italian).

Procedure

1. Translation and Certification

1. Identify documents requiring translation (ICF, PIS, recruitment materials).
2. Engage certified translators familiar with medical terminology.
3. Perform back-translation to confirm accuracy.
4. File Certificate of Translation Accuracy in TMF (Annexure-1).

2. Submission to BASEC and Swissmedic

1. Submit multilingual documents as part of initial trial dossier or amendments.
2. Record acknowledgment in Submission Log.

3. Subject-Facing Documents

1. Ensure ICFs and PIS are provided in German, French, or Italian depending on trial location.
2. Confirm participant comprehension during the consent process.

4. Retention of Records

1. Maintain TMF and ISF records in compliance with Swiss ClinO retention requirements (at least 10 years).
2. For medical device trials under ClinO-MD, retain records for a minimum of 15 years.
3. Maintain digital backups of archived records.

5. Quality Control and Auditing

1. QA team conducts periodic checks of translated materials.
2. Ensure retention timelines are tracked in Retention Log (Annexure-2).

Abbreviations

• ClinO: Ordinance on Clinical Trials in Human Research
• ClinO-MD: Ordinance on Clinical Trials with Medical Devices
• Swissmedic: Swiss Agency for Therapeutic Products
• BASEC: Business Administration System for Ethics Committees
• ICF: Informed Consent Form
• PIS: Patient Information Sheet
• PI: Principal Investigator
• RA: Regulatory Affairs
• QA: Quality Assurance
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. Certificate of Translation Accuracy (Annexure-1)
2. Retention Log (Annexure-2)
3. Submission Log (Annexure-3)

References

• Swissmedic — Clinical Trials
• Swiss Ethics Committees (BASEC)
• ICH E6(R2) Good Clinical Practice

Version: 1.0

Approval

Annexures

Annexure-1: Certificate of Translation Accuracy

Annexure-2: Retention Log

Annexure-3: Submission Log

Revision History

For more SOPs visit: Pharma SOP.

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sae-and-susar-reporting-to-swissmedic”
},
“@id”: “https://www.clinicalstudies.in/sae-and-susar-reporting-to-swissmedic”,
“headline”: “SOP for SAE and SUSAR Reporting to Swissmedic”,
“name”: “SOP for SAE and SUSAR Reporting to Swissmedic”,
“description”: “Detailed SOP describing investigator, sponsor, and CRO responsibilities for SAE and SUSAR reporting to Swissmedic and BASEC in compliance with Swiss GCP and ClinO requirements.”,
“keywords”: “SAE reporting SOP Switzerland, SUSAR reporting SOP Switzerland, Swissmedic safety reporting SOP, SOP for expedited reporting Swissmedic, SOP for EC safety reporting Switzerland, SOP for investigator responsibilities SAE Switzerland, SOP for sponsor obligations Swissmedic SUSAR, SOP for pharmacovigilance Swiss clinical trials, SOP for DSUR submission Switzerland, SOP for SAE documentation Switzerland, SOP for SUSAR narrative Switzerland, SOP for BASEC safety submissions, SOP for inspection readiness safety reporting Switzerland, SOP for safety reporting timelines Switzerland, SOP for safety governance Swiss trials, SOP for safety case management Switzerland, SOP for PV compliance Switzerland, SOP for CRO safety support Switzerland, SOP for sponsor QPPV responsibilities Switzerland, SOP for site safety record keeping Switzerland, SOP for trial subject protection Switzerland, SOP for adverse reaction reporting Switzerland, SOP for safety database management Switzerland, SOP for safety reporting logs Switzerland, SOP for safety reporting archiving Switzerland”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

SAE and SUSAR Reporting to Swissmedic SOP

Purpose

This SOP establishes procedures for reporting Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs) to Swissmedic and Ethics Committees (via BASEC). It ensures compliance with ClinO, ICH GCP, and subject safety protection requirements.

Scope

This SOP applies to all sponsor-led and investigator-initiated clinical trials conducted in Switzerland. It includes SAE detection, documentation, causality assessment, expedited SUSAR reporting, Development Safety Update Report (DSUR) submissions, and safety case archiving. It is applicable to sponsors, CROs, investigators, PV teams, and regulatory affairs staff.

Responsibilities

• Principal Investigator (PI): Detects and reports SAEs to the sponsor within 24 hours, ensures SAE forms are completed, and files in ISF.
• Clinical Research Coordinator (CRC): Assists in documenting and reporting SAEs.
• Sponsor PV Team: Assesses seriousness, expectedness, and causality; prepares SUSARs; and ensures submissions to Swissmedic.
• Regulatory Affairs (RA): Confirms Swissmedic and BASEC acknowledgments are received and logged.
• Quality Assurance (QA): Monitors PV systems and ensures inspection readiness.
• CRO: Supports sponsor in safety reporting activities if delegated.

Accountability

The Qualified Person for Pharmacovigilance (QPPV) or equivalent in Switzerland is accountable for compliance with SAE and SUSAR reporting obligations. The PI is accountable for timely and accurate SAE reporting at the site.

Procedure

1. SAE Identification and Initial Documentation

1. All SAEs must be recorded within 24 hours of investigator awareness using SAE forms.
2. Initial SAE reports must include subject ID, event description, onset date, severity, causality, and outcome.
3. Copies of completed SAE reports must be filed in ISF and sent to sponsor.

2. SUSAR Reporting Timelines

1. Fatal or life-threatening SUSARs: Submit to Swissmedic and BASEC within 7 calendar days, with follow-up data within 8 days.
2. Other SUSARs: Submit within 15 calendar days.

3. Safety Data Submission

1. Submit expedited reports electronically via Swissmedic’s pharmacovigilance portal.
2. Ensure DSURs are submitted annually with cumulative safety data.

4. Follow-Up Information

1. Collect and document follow-up details for all SUSARs.
2. Submit updates to Swissmedic and BASEC promptly.

5. Documentation and Archiving

1. Maintain SAE/SUSAR logs, narratives, DSURs, and acknowledgment receipts in TMF.
2. Archive safety records for at least 10 years in accordance with ClinO requirements.

Abbreviations

• SAE: Serious Adverse Event
• SUSAR: Suspected Unexpected Serious Adverse Reaction
• DSUR: Development Safety Update Report
• PI: Principal Investigator
• CRC: Clinical Research Coordinator
• PV: Pharmacovigilance
• RA: Regulatory Affairs
• QA: Quality Assurance
• QPPV: Qualified Person for Pharmacovigilance
• TMF: Trial Master File
• ISF: Investigator Site File
• BASEC: Business Administration System for Ethics Committees

Documents

1. SAE Form (Annexure-1)
2. SUSAR Log (Annexure-2)
3. DSUR Submission Log (Annexure-3)

References

• Swissmedic — Safety Reporting
• BASEC — Ethics Committees Switzerland
• ICH E2A: Clinical Safety Data Management
• ICH E2F: Development Safety Update Report

Version: 1.0

Approval

Annexures

Annexure-1: SAE Form

Annexure-2: SUSAR Log

Annexure-3: DSUR Submission Log

Revision History

For more SOPs visit: Pharma SOP.

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/multilingual-documentation-and-retention-compliance”
},
“@id”: “https://www.clinicalstudies.in/multilingual-documentation-and-retention-compliance”,
“headline”: “SOP for Multilingual Documentation and Retention Compliance”,
“name”: “SOP for Multilingual Documentation and Retention Compliance”,
“description”: “Comprehensive SOP describing sponsor, investigator, and CRO responsibilities for preparing multilingual documentation and adhering to Swiss retention requirements for clinical trial documents.”,
“keywords”: “Swissmedic document retention SOP, clinical trial archiving SOP Switzerland, multilingual trial documents Switzerland, SOP for translation and retention Switzerland, SOP for ethics submissions multilingual, SOP for Swiss trial records retention, SOP for sponsor archiving obligations Switzerland, SOP for investigator responsibilities document retention, SOP for GCP compliance Switzerland, SOP for document authenticity Switzerland, SOP for trial master file retention Switzerland, SOP for ISF archiving Switzerland, SOP for translation vendor SOP Switzerland, SOP for subject-facing documents multilingual Switzerland, SOP for clinical trial translation QA Switzerland, SOP for ethics approval documentation Switzerland, SOP for inspection readiness archiving Switzerland, SOP for retention rules Switzerland ClinO, SOP for multilingual ICF Switzerland, SOP for safety report retention Switzerland, SOP for trial lifecycle documentation Switzerland, SOP for TMF and ISF compliance Switzerland, SOP for archival facilities Switzerland, SOP for patient document retention Switzerland, SOP for archiving governance Switzerland”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Multilingual Documentation and Retention Compliance SOP

Purpose

The purpose of this SOP is to establish clear processes for preparing multilingual documentation and ensuring compliance with Swiss retention rules for clinical trial records. It ensures ethical, regulatory, and scientific integrity by meeting Swissmedic, BASEC, and ICH GCP requirements.

Scope

This SOP applies to all clinical trials conducted in Switzerland. It covers the translation, certification, back-translation, submission, and archiving of essential trial documents such as informed consent forms, protocols, investigator brochures, patient materials, and safety reports. It applies to sponsors, investigators, CROs, regulatory affairs staff, and translation vendors.

Responsibilities

• Sponsor: Ensures that all documents requiring translation are prepared in the required national languages and retained per retention rules.
• Regulatory Affairs (RA): Submits multilingual documents to Swissmedic and BASEC and records acknowledgments.
• Principal Investigator (PI): Provides subject-facing translated documents to participants and maintains ISF per retention timelines.
• Translation Vendor: Supplies certified translations and ensures accuracy via back-translation.
• Quality Assurance (QA): Audits translation processes and retention logs for compliance.

Accountability

The Sponsor’s Head of Clinical Operations is accountable for multilingual documentation compliance. The PI is accountable for ensuring subject-facing materials are accurate and archived correctly at site level.

Procedure

1. Identification of Required Translations

1. Determine which documents require translation based on trial location (German, French, Italian regions).
2. Document translation requirements in Translation Tracker (Annexure-1).

2. Translation and Verification

1. Engage certified medical translators for trial documents.
2. Perform back-translation for critical documents (ICFs, patient leaflets).
3. File Certificate of Translation in TMF.

3. Submission to Authorities

1. Submit translated documents to Swissmedic and BASEC through electronic portals.
2. Record approvals and acknowledgments in Submission Log (Annexure-2).

4. Retention Rules

1. Retain TMF and ISF documents for at least 10 years as per ClinO.
2. For device trials (ClinO-MD), retain for 15 years.
3. Ensure retention logs are updated annually.

5. Archiving

1. Archive records in secure physical or digital facilities with restricted access.
2. Backups must be maintained in a separate secure location.

Abbreviations

• ClinO: Ordinance on Clinical Trials in Human Research
• ClinO-MD: Ordinance on Clinical Trials with Medical Devices
• Swissmedic: Swiss Agency for Therapeutic Products
• BASEC: Business Administration System for Ethics Committees
• ICF: Informed Consent Form
• TMF: Trial Master File
• ISF: Investigator Site File
• RA: Regulatory Affairs
• QA: Quality Assurance
• PI: Principal Investigator

Documents

1. Translation Tracker (Annexure-1)
2. Submission Log (Annexure-2)
3. Retention Log (Annexure-3)

References

• Swissmedic — Clinical Trials
• Swiss Ethics Committees (BASEC)
• ICH E6(R2) Good Clinical Practice

Version: 1.0

Approval

Annexures

Annexure-1: Translation Tracker

Annexure-2: Submission Log

Annexure-3: Retention Log

Revision History

For more SOPs visit: Pharma SOP.

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sae-and-susar-reporting-to-swissmedic”
},
“@id”: “https://www.clinicalstudies.in/sae-and-susar-reporting-to-swissmedic”,
“headline”: “SOP for SAE and SUSAR Reporting to Swissmedic”,
“name”: “SOP for SAE and SUSAR Reporting to Swissmedic”,
“description”: “Detailed SOP outlining sponsor, investigator, and CRO responsibilities for SAE and SUSAR reporting to Swissmedic and BASEC in Switzerland, aligned with ClinO and ICH GCP standards.”,
“keywords”: “SAE reporting SOP Switzerland, SUSAR reporting SOP Switzerland, Swissmedic pharmacovigilance SOP, SOP for safety case submissions Switzerland, SOP for expedited SUSAR submissions Switzerland, SOP for DSUR submission Swissmedic, SOP for investigator responsibilities SAE reporting, SOP for sponsor pharmacovigilance obligations Switzerland, SOP for site safety record keeping Switzerland, SOP for ICSR submissions Swissmedic, SOP for CRO safety management Switzerland, SOP for regulatory compliance Swiss safety reporting, SOP for safety data management Switzerland, SOP for annual safety updates Switzerland, SOP for trial subject safety Switzerland, SOP for adverse reaction reporting Switzerland, SOP for BASEC safety reporting Switzerland, SOP for PV inspection readiness Switzerland, SOP for regulatory timelines SAE SUSAR Switzerland, SOP for SAE documentation Switzerland, SOP for SUSAR narrative Switzerland, SOP for pharmacovigilance database compliance Switzerland, SOP for GCP safety governance Switzerland, SOP for sponsor QA pharmacovigilance Switzerland, SOP for clinical trial safety submissions Switzerland”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

SAE and SUSAR Reporting to Swissmedic SOP

Purpose

The purpose of this SOP is to define a clear, regulatory-compliant process for reporting Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs) in Switzerland. It ensures compliance with the Ordinance on Clinical Trials (ClinO), ICH GCP, Swissmedic requirements, and ethics committee oversight, thereby safeguarding trial subjects and maintaining trial credibility.

Scope

This SOP applies to all sponsor-led and investigator-initiated clinical trials in Switzerland. It covers SAE detection, documentation, causality assessment, SUSAR expedited reporting, Development Safety Update Report (DSUR) submissions, and archiving. It applies to sponsors, investigators, CROs, pharmacovigilance teams, and regulatory affairs staff.

Responsibilities

• Principal Investigator (PI): Identifies and documents SAEs, ensures initial notification to the sponsor within 24 hours, and files SAE forms in ISF.
• Clinical Research Coordinator (CRC): Supports the PI in SAE reporting and maintains site safety documentation.
• Sponsor Pharmacovigilance (PV) Team: Assesses causality, expectedness, and seriousness, prepares SUSAR submissions, and ensures compliance with timelines.
• Regulatory Affairs (RA): Submits SUSARs and DSURs to Swissmedic and BASEC, ensuring acknowledgment receipts are filed.
• Quality Assurance (QA): Conducts audits of safety documentation and ensures inspection readiness.
• CRO (if applicable): Provides PV support and manages delegated reporting activities.

Accountability

The Qualified Person for Pharmacovigilance (QPPV) or designated Swiss safety officer is accountable for ensuring all SAE and SUSAR reporting obligations are met. The PI is accountable for timely identification and reporting of safety events at site level.

Procedure

1. SAE Identification and Reporting

1. Record all SAEs in SAE forms within 24 hours of awareness.
2. Send SAE reports to sponsor PV team for assessment.
3. File all SAE documentation in ISF.

2. SUSAR Reporting Timelines

1. Fatal or life-threatening SUSARs: submit within 7 calendar days to Swissmedic and BASEC, with follow-up within 8 days.
2. Other SUSARs: submit within 15 calendar days.

3. Data Entry and Submission

1. Submit SUSARs electronically via Swissmedic’s reporting system.
2. Ensure DSURs are prepared annually and submitted within 60 days of data lock point.

4. Follow-Up Reporting

1. Collect additional information for all SUSARs and submit updated reports.
2. Ensure BASEC is informed of safety updates.

5. Documentation and Archiving

1. Maintain SAE and SUSAR logs in TMF and ISF.
2. Archive all safety documentation for at least 10 years in compliance with ClinO.

Abbreviations

• SAE: Serious Adverse Event
• SUSAR: Suspected Unexpected Serious Adverse Reaction
• DSUR: Development Safety Update Report
• PI: Principal Investigator
• CRC: Clinical Research Coordinator
• PV: Pharmacovigilance
• RA: Regulatory Affairs
• QA: Quality Assurance
• QPPV: Qualified Person for Pharmacovigilance
• TMF: Trial Master File
• ISF: Investigator Site File
• BASEC: Business Administration System for Ethics Committees
• ClinO: Ordinance on Clinical Trials in Human Research

Documents

1. SAE Form (Annexure-1)
2. SUSAR Log (Annexure-2)
3. DSUR Submission Tracker (Annexure-3)

References

• Swissmedic — Safety Reporting
• Swiss Ethics Committees (BASEC)
• ICH E2A: Clinical Safety Data Management
• ICH E2F: Development Safety Update Report

Version: 1.0

Approval

Annexures

Annexure-1: SAE Form

Annexure-2: SUSAR Log

Annexure-3: DSUR Submission Tracker

Revision History

For more SOPs visit: Pharma SOP.